Fig. 2
From: PD-L1 tumour expression is predictive of pazopanib response in soft tissue sarcoma
Maximum response to pazopanib in patients with STS. (a) The waterfall plot represents percentage of maximum tumour reduction in response to treatment, assessed according to RECIST 1.1 criteria. * indicates newly developed lesions per RECIST 1.1. (b) Prevalence of PD-L1 expression in responders (PR) and non-responders (SD, PD), assessed according to RECIST 1.1 criteria. (c) Maximum tumour reduction according to histological subtypes and PD-L1 status. PD-L1 TPS score (≥1%) has been plotted on the X-axis and PD-L1 positive marked in light color bars. Indicates rhabdomyosarcoma and ¥ indicates ASPS (Alveolar soft part sarcoma). Abbreviation: Soft tissue sarcoma (STS), Response Evaluation Criteria in Solid Tumors (RECIST) 1.1, Programmed death-ligand 1(PD-L1), tumour proportion score (TPS), PR (partial response), SD (stable disease), PD (progression disease). *This figure was generated with Microsoft Excel